Over the past 10 years, the interest in intranasal drug delivery in pharmaceutical R&D has
increased. This review article summarises information on intranasal administration for local …

While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …

Background Experimental studies and small clinical trials have suggested that treatment
with intranasal oxytocin may reduce social impairment in persons with autism spectrum …

The ability to represent mental states (theory of mind [ToM]) is crucial in understanding
individual differences in social ability and social impairments evident in conditions such as …

An expert review of the aetiology, assessment, and treatment of autism spectrum disorder,
and recommendations for diagnosis, management and service provision was coordinated …

Autism spectrum disorder (ASD) is characterized by core social deficits. Prognosis is poor, in
part, because existing medications target only associated ASD features. Emerging evidence …

Interventions for autism are limited. The synthetic hormone oxytocin may provide a potential
treatment to improve core social and behavioral difficulties in autism, but its efficacy has yet …

Autism spectrum disorder (ASD) is a common neurodevelopmental disorder characterized
by pervasive difficulties since early childhood across reciprocal social communication and …

Autism is a pervasive developmental disorder characterized by profound social and verbal
communication deficits, stereotypical motor behaviors, restricted interests, and cognitive …

We report that the oxytocin-mediated neuroprotective γ-aminobutyric acid (GABA) excitatory-
inhibitory shift during delivery is abolished in the valproate and fragile X rodent models of …